A Prospective, Multi-Center, Single Arm Study to evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device and Delivery System when used in conjunction with Endovascular Coil Embolization in the Treatment of Wide-Necked Saccular Intracranial Aneurysms.
Author
Donald Frei, MDNeuroInterventional Surgeon based in Denver, Colorado
Intravenous (IV) tissue plasminogen activator (tPA) administration has been shown to be safe and effective for treatment of Acute Ischemic Stroke (AIS) within 3 hours of symptom onset, and newer evidence has shown potential benefit out to 4.5 hours.
StrokeNet, developed by NIH, is the new structure for federal funding of all aspects of stroke research including prevention, acute treatment, and recovery / rehabilitation.
RIA has a rich history of participation in clinical research and innovation dating back to the 1980s. Many of our physicians believe it is important to contribute to science and advance medicine.
The full name of this study is: Barrel™: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device for Adjunctive Treatment to Embolic Coils for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms.
